Soliman Mahmoud M, Macky Tamer A, Samir M Khaled
Department of Ophthalmology, Kasr El Aini Hospital, Cairo University, El-Manial, 16 Sherif Street, Cairo 11111, Egypt.
J Cataract Refract Surg. 2004 Aug;30(8):1716-20. doi: 10.1016/j.jcrs.2003.12.034.
To assess the efficacy of lidocaine gel, bupivacaine drops, and benoxinate drops as topical anesthetic agents in cataract surgery.
Kasr El-Aini Hospital, Cairo University, Cairo, Egypt.
This prospective randomized study comprised 90 patients scheduled for routine cataract extraction. Patients were randomized into 3 groups of 30 each based on which anesthetic agent they received: lidocaine 2% gel, bupivacaine 0.5% drops, or benoxinate 0.4% drops. Subjective pain at application of the agent and intraoperatively was quantified by the patients using a verbal pain score (VPS) scale from 0 to 10. The duration of discomfort at application, duration of surgery, rate of supplemental sub-Tenon's anesthesia, and complications were recorded.
The mean VPS at application was 2.97, 1.53, and 1.03 in the lidocaine, bupivacaine, and benoxinate groups, respectively; the VPS in the lidocaine group was statistically significantly higher than in the other 2 groups (P<.001). The mean duration of pain at application was 25 seconds, 14 seconds, and 6 seconds in the lidocaine, bupivacaine, and benoxinate groups, respectively, and was statistically significantly higher in the lidocaine group (P<.001). The mean VPS during surgery was 1.6, 4.1, and 7.1 in the lidocaine, bupivacaine, and benoxinate groups; the lidocaine group had a statistically significantly lower mean VPS than the other 2 groups (P<.001). The incidence of supplemental sub-Tenon's injection was 3.3%, 10.0%, and 73.3%, respectively, and was statistically significantly lower in the lidocaine and bupivacaine groups than in the benoxinate group (P<.001). The patients' overall satisfaction was statistically significantly higher in the lidocaine and bupivacaine groups than in the benoxinate group (93.3%, 83.3%, and 33.3%, respectively) (P<.001). Three patients in the lidocaine group had corneal haze at the time of surgery, which was not statistically significant (P>.1).
Lidocaine gel was a better topical anesthetic agent than bupivacaine and benoxinate drops. Bupivacaine drops were effective in providing deep topical anesthesia.
评估利多卡因凝胶、布比卡因滴眼液和丁卡因滴眼液作为白内障手术局部麻醉剂的疗效。
埃及开罗开罗大学卡斯尔·艾尼医院。
这项前瞻性随机研究纳入了90例计划进行常规白内障摘除术的患者。根据所接受的麻醉剂,患者被随机分为3组,每组30人:2%利多卡因凝胶、0.5%布比卡因滴眼液或0.4%丁卡因滴眼液。患者使用0至10的言语疼痛评分(VPS)量表对使用麻醉剂时和术中的主观疼痛进行量化。记录使用麻醉剂时的不适持续时间、手术持续时间、补充球后麻醉的发生率和并发症。
利多卡因组、布比卡因组和丁卡因组使用麻醉剂时的平均VPS分别为2.97、1.53和1.03;利多卡因组的VPS在统计学上显著高于其他2组(P<0.001)。利多卡因组、布比卡因组和丁卡因组使用麻醉剂时的平均疼痛持续时间分别为25秒、14秒和6秒,利多卡因组在统计学上显著更长(P<0.001)。利多卡因组、布比卡因组和丁卡因组术中的平均VPS分别为1.�、4.1和7.1;利多卡因组的平均VPS在统计学上显著低于其他2组(P<0.001)。补充球后注射的发生率分别为3.3%、10.0%和73.3%,利多卡因组和布比卡因组在统计学上显著低于丁卡因组(P<0.001)。利多卡因组和布比卡因组患者的总体满意度在统计学上显著高于丁卡因组(分别为93.3%、83.3%和33.3%)(P<0.001)。利多卡因组有3例患者在手术时出现角膜混浊,差异无统计学意义(P>0.1)。
利多卡因凝胶是比布比卡因和丁卡因滴眼液更好的局部麻醉剂。布比卡因滴眼液在提供深度局部麻醉方面有效。